Role of Immunological Memory Cells as a Therapeutic Target in Multiple Sclerosis
AbstractPharmacological targeting of memory cells is an attractive treatment strategy in various autoimmune diseases, such as psoriasis and rheumatoid arthritis. Multiple sclerosis is the most common inflammatory disorder of the central nervous system, characterized by focal immune cell infiltration, activation of microglia and astrocytes, along with progressive damage to myelin sheaths, axons, and neurons. The current review begins with the identification of memory cell types in the previous literature and a recent description of the modulation of these cell types in T, B, and resident memory cells in the presence of different clinically approved multiple sclerosis drugs. Overall, this review paper tries to determine the potential of memory cells to act as a target for the current or newly-developed drugs. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Bose, T. Role of Immunological Memory Cells as a Therapeutic Target in Multiple Sclerosis. Brain Sci. 2017, 7, 148.
Bose T. Role of Immunological Memory Cells as a Therapeutic Target in Multiple Sclerosis. Brain Sciences. 2017; 7(11):148.Chicago/Turabian Style
Bose, Tanima. 2017. "Role of Immunological Memory Cells as a Therapeutic Target in Multiple Sclerosis." Brain Sci. 7, no. 11: 148.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.